PRODUCT
Summary
CD229 peptide is used for blocking the activity of CD229 antibody (catalog number GTX31832).
APPLICATION
Application Note
*Optimal dilutions/concentrations should be determined by the researcher.
Application |
Recommended Dilution |
Assay dependent |
Not tested in other applications.
PROPERTIES
Form
Liquid
Buffer
PBS, 0.1% BSA
Preservative
0.02% Sodium azide
Storage
Store as concentrated solution. Aliquot and store at -20ºC or below. Avoid freeze-thaw cycles.
Concentration
200 μg/ml (Please refer to the vial label for the specific concentration.)
Conjugation
Unconjugated
Note
For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.
TARGET
Synonyms
Lymphocyte Antigen 9 , Cd229 , Slamf3 , Hly9 , Mly9 , Ly9
Background
LY9 belongs to the SLAM family of immunomodulatory receptors (see SLAMF1; MIM 603492) and interacts with the adaptor molecule SAP (SH2D1A; MIM 300490) (Graham et al., 2006 [PubMed 16365421]).[supplied by OMIM, Mar 2008]
Research Area
REFERENCE
There are currently no references for CD229 blocking peptide (GTX31832-PEP). Be the first to share your publications with this product.
REVIEW
There are currently no reviews for CD229 blocking peptide (GTX31832-PEP). Be the first to share your experience with this product.